FLORESTA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 5.126
EU - Europa 3.755
AS - Asia 3.378
SA - Sud America 502
AF - Africa 422
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.196
Nazione #
US - Stati Uniti d'America 4.986
IT - Italia 1.654
SG - Singapore 1.577
RU - Federazione Russa 1.132
CN - Cina 930
BR - Brasile 410
IE - Irlanda 289
VN - Vietnam 250
KR - Corea 237
CI - Costa d'Avorio 231
FR - Francia 151
DE - Germania 97
CA - Canada 86
GB - Regno Unito 82
NG - Nigeria 76
BD - Bangladesh 63
IN - India 62
HK - Hong Kong 52
NL - Olanda 51
FI - Finlandia 50
SE - Svezia 45
MX - Messico 40
ES - Italia 37
JP - Giappone 35
AR - Argentina 34
PL - Polonia 31
CZ - Repubblica Ceca 30
UA - Ucraina 30
ZA - Sudafrica 28
TR - Turchia 27
ID - Indonesia 25
IQ - Iraq 24
SN - Senegal 19
BJ - Benin 18
EC - Ecuador 16
IR - Iran 15
AT - Austria 14
CH - Svizzera 12
MA - Marocco 12
VE - Venezuela 12
AU - Australia 11
CO - Colombia 11
EG - Egitto 11
PK - Pakistan 11
MY - Malesia 10
CL - Cile 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
KE - Kenya 7
BE - Belgio 6
LB - Libano 6
PT - Portogallo 6
TN - Tunisia 6
DZ - Algeria 5
GR - Grecia 5
JO - Giordania 5
PY - Paraguay 5
SA - Arabia Saudita 5
AL - Albania 4
BG - Bulgaria 4
BO - Bolivia 4
ET - Etiopia 4
JM - Giamaica 4
NP - Nepal 4
SY - Repubblica araba siriana 4
GA - Gabon 3
HR - Croazia 3
KZ - Kazakistan 3
LT - Lituania 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AZ - Azerbaigian 2
BB - Barbados 2
CY - Cipro 2
DK - Danimarca 2
HU - Ungheria 2
IL - Israele 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
RO - Romania 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MZ - Mozambico 1
Totale 13.188
Città #
Singapore 991
Dallas 815
Santa Clara 583
Moscow 544
San Jose 505
Chandler 439
Catania 397
Hefei 359
Ashburn 336
Chicago 303
Dublin 289
Seoul 235
Abidjan 231
Beijing 161
Civitanova Marche 152
Los Angeles 145
Boardman 134
Houston 131
Lauterbourg 103
Ho Chi Minh City 85
Council Bluffs 77
Rome 75
New York 71
Cambridge 59
Lawrence 59
Naples 59
Hanoi 56
Andover 52
Palermo 46
Hong Kong 45
Milan 44
Buffalo 42
Lagos 41
Bremen 39
São Paulo 36
The Dalles 35
Columbus 34
Nanjing 34
Des Moines 32
Tokyo 32
Lappeenranta 30
Orem 30
San Giovanni la Punta 28
Montreal 27
Amsterdam 26
Toronto 26
Warsaw 26
Brooklyn 25
Denver 25
Florence 25
Jacksonville 24
Munich 22
Brno 21
Abuja 19
Atlanta 19
Dakar 19
Dong Ket 19
Misterbianco 19
Phoenix 19
Cotonou 18
Sala Baganza 18
San Francisco 18
Stockholm 18
Johannesburg 17
Messina 17
Jakarta 16
Mexico City 16
Port Harcourt 16
Wilmington 16
Bari 15
Salerno 15
Baghdad 14
Belpasso 14
Boston 14
Boydton 14
Helsinki 14
Washington 14
London 13
Rio de Janeiro 13
Tehran 13
Acireale 12
Haiphong 12
Mascalucia 12
Poplar 12
Manchester 11
Porto San Giorgio 11
Reggio Calabria 11
Saint Petersburg 11
Seattle 11
Bologna 10
Brugherio 10
Chennai 10
Groningen 10
Lecce 10
Madrid 10
Villafranca Tirrena 10
Marseille 9
Ottawa 9
Vienna 9
Aci Catena 8
Totale 8.886
Nome #
Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS-CoV-2 198
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent in Vitro Antiproliferative Activity 192
[1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT7 receptor 188
DNA intercalators based on (1,10-phenanthrolin-2-yl)isoxazolidin-5-yl core with better growth inhibition and selectivity than cisplatin upon head and neck squamous cells carcinoma 180
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 176
A pseudouridine isoxazolidinyl nucleoside analogue structural analysis: A morphological approach 169
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application 167
Carbamoyl-Decorated Cyclodextrins for Carbon Dioxide Adsorption 164
Cucurbit[7]uril as a catalytic nanoreactor for one-pot synthesis of isoxazolidines in water 164
A structure-and ligand-based virtual screening of a database of “small” marine natural products for the identification of “blue” sigma-2 receptor ligands 161
Conversion of VOC-derived CO2 into sustainable products with a natural magnetic alginate composite 156
A Rare Natural Benzo[k,l]xanthene as a Turn-Off Fluorescent Sensor for Cu2+ Ion 155
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 154
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study 152
3D-QSAR assisted identification of FABP4 inhibitors: An effective scaffold hopping analysis/QSAR evaluation 152
Ammidi dell’acido rosmarinico come potenziali agenti antidiabetici 149
Artificial Intelligence Technologies for COVID-19 De Novo Drug Design 148
CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications 146
Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers 143
Computational tools in the discovery of FABP4 ligands: A statistical and molecular modeling approach 142
H2 production by solar photoreforming of plastic materials using SiC-g-C3N4composites 141
Design of Small Molecules for Oncological and Neurodegenerative Diseases 140
A hexameric resorcinarene capsule as a hydrogen bonding catalyst in the conjugate addition of pyrroles and indoles to nitroalkenes 139
γ-Cyclodextrins as Supramolecular Reactors for the Three-component Aza-Darzens Reaction in Water 135
Nature-inspired innovation: Alginic-kojic acid material for sustainable antibacterial and carbon dioxide fixation 134
Green efficient one‐pot synthesis and separation of nitrones in water assisted by a self‐assembled nanoreactor 134
Total Bio-Based Material for Drug Delivery and Iron Chelation to Fight Cancer through Antimicrobial Activity 132
New arylethanolimidazole derivatives as HO-1 inhibitors with cytotoxicity against MCF-7 breast cancer cells 132
La modellistica molecolare applicata ai recettori Sigma-1 e Sigma-2: un excursus 131
Functionalization of single and multi-walled carbon nanotubes with polypropylene glycol decorated pyrrole for the development of doxorubicin nano-conveyors for cancer drug delivery 131
Development of NO-releasing sigma receptor hybrids as anticancer agents 128
Computer-Assisted Design of Peptide-Based Radiotracers 127
Mild Friedel–Crafts Reactions inside a Hexameric Resorcinarene Capsule: C−Cl Bond Activation through Hydrogen Bonding to Bridging Water Molecules 127
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022 127
Fourfold filtered statistical/computational approach for the identification of imidazole compounds as HO-1 inhibitors from natural products 125
Sigma-2 receptor ligands QSAR model dataset 124
Novel structural insight into inhibitors of heme oxygenase-1 (ho-1) by new imidazole-based compounds: Biochemical and in vitro anticancer activity evaluation 124
c-Met Receptor PET Imaging Probes for Cancer Detection and Monitoring 123
Molecular modeling studies of pseudouridine isoxazolidinyl nucleoside analogues as potential inhibitors of the pseudouridine 5'-monophosphate glycosidase 123
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new? 123
The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat 122
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 120
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 118
Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region 118
An integrated pharmacophore/docking/3D-QSAR approach to screening a large library of products in search of future botulinum neurotoxin a inhibitors 117
Designing a monolithic photo-Fenton catalyst using a fungal hydroxypyrone metabolic derivative 117
Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques 117
Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia 117
Supramolecular biomaterials as drug nanocontainers with iron depletion properties for antimicrobial applications 116
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. 116
Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43 115
Development of new HO-1 inhibitors by a thorough scaffold-hopping analysis 115
Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach† 115
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 115
Portable Nanocomposite System for Wound Healing in Space 115
‘Main Mechanical Forces‐Chemical Interactions’ Interplay as a Tool to Elucidate Folding Mechanisms 113
Intramolecular oxidative palladium-​catalyzed diamination reactions of alkenyl sulfamates: an efficient synthesis of [1,​2,​5]​thiadiazolo-​fused piperazinones 113
Unveiling the chemistry of antibody conjugation for enhanced PET imaging: Current trends and future directions 112
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022 112
Structural, morphological, and modeling studies of N-(benzoyloxy)benzamide as a specific inhibitor of Type II inosine monophosphate dehydrogenase 111
Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose 111
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 110
Developing Advanced Antibacterial Alginic Acid Biomaterials through Dual Functionalization 107
Learning Strategies from Nature's Blueprint to Cyclic Carbonate Synthesis 107
FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets 107
Halloysite-kojic acid conjugate: A sustainable material for the photocatalytic CO2 reduction and fixation for cyclic carbonates production 107
Efficient green solvent-free CO2/epoxide cycloaddition catalyzed by a β-cyclodextrin-imidazolium-based ionic liquid 106
Natural antenna molecule in halloysite-kojic acid composite for the solar photocatalytic CO2 methanation 105
Evidence-based successful example of a structure-based approach for the prediction of designer fentanyl-like molecules 102
Synthesis of Rosmarinic Acid Amides as Antioxidative and Hypoglycemic Agents 102
Growing the molecular architecture of imidazole-like ligands in HO-1 complexes 102
HEMA-based macro and microporous materials for CO2 capture 101
γ-Cyclodextrin as a Catalyst for the Synthesis of 2-Methyl-3,5-diarylisoxazolidines in Water 100
Solvent-free conversion of CO2 in carbonates through a sustainable macroporous catalyst 98
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach 97
Current Chemistry behind Peptide-based PET Probes 11C and18F 97
Physicochemical characterization and antioxidant activity evaluation of idebenone/hydroxypropyl-β-cyclodextrin inclusion complex 96
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis 95
THP as a sensor for the electrochemical detection of H2O2 95
From far west to east: Joining the molecular architecture of imidazole-like ligands in ho-1 complexes 94
Towards identifying nicomorphine administration in doping control: Synthesis of metabolites 94
Tetrazine–trans-cyclooctene ligation: Unveiling the chemistry and applications within the human body 93
Semaglutide as a Possible Calmodulin Binder: Ligand-Based Computational Analyses and Relevance to Its Associated Reward and Appetitive Behaviour Actions 93
Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis 93
TiO2/Loofah–Halloysite Bio–Hybrid Composites as Efficient Systems for VOCs Removal 92
Illuminating the Path to Target GPCR Structures and Functions 91
Design and synthesis of novel compounds as fatty acids binding protein inhibitors and as gallium-68 chelators for positron emission tomography 89
Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors 89
Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors 88
Synergic Interplay Between Halogen Bonding and Hydrogen Bonding in the Activation of a Neutral Substrate in a Nanoconfined Space 85
Halloysite-based multifunctional filler for antibacterial and anticorrosive protective coatings: a sustainable approach using kojic acid and ionic liquids 84
Evidence of enzyme-mediated transesterification of synthetic cannabinoids with ethanol: potential toxicological impact 83
The hexameric resorcinarene capsule as an artificial enzyme: Ruling the regio and stereochemistry of a 1,3-dipolar cycloaddition between nitrones and unsaturated aldehydes 83
Targeting integrin αvβ6 with gallium-68 tris (hydroxypyridinone) based PET probes 82
Structure-based approach for the prediction of mu-opioid binding affinity of unclassified designer fentanyl-like molecules 81
Supramolecular host-guest interactions of pseudoginsenoside F11 with β- and γ-cyclodextrin: Spectroscopic/spectrometric and computational studies 80
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents 79
Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process 77
Exploration of nitrogen heterocycle scaffolds for the development of potent human neutrophil elastase inhibitors 77
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition 75
Totale 11.917
Categoria #
all - tutte 41.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.031


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 0 17
2021/2022486 20 60 27 4 86 6 77 26 38 22 12 108
2022/20231.280 93 80 57 174 107 191 20 182 255 24 68 29
2023/2024910 55 122 68 51 50 183 33 46 33 39 125 105
2024/20253.135 100 452 157 266 506 297 199 149 222 274 248 265
2025/20266.992 444 585 1.046 477 966 1.326 641 196 471 422 341 77
Totale 13.532